When patients arrive for a cardiac MRI at Health First’s Holmes Regional Medical Center, they may not realize that while they lie still in the scanner.
In fact, among Medicare beneficiaries aged 65 years or older, the incidence of transthyretin cardiac amyloidosis (ATTR-CM) diagnoses rose from about 10.1 per 100,000 person-years ...
The SmartHeart AI-powered MR workflow. [Image courtesy of Philips] Philips (NYSE: PHG) + announced today that it received FDA 510(k) clearance for its SmartHeart planning solution. SmartHeart, an ...
Philips has received FDA 510(k) clearance for SmartHeart, an AI-powered planning tool that automates one of the most complex MRI exams: cardiac MR. The system generates 14 standard and advanced ...
Guam Regional Medical City launched an innovative, state-of-the-art heart imaging test: Computed tomography of the heart with quantitative evaluation of coronary calcium, coronary artery analysis, ...
Rural cardiovascular disparities and limited specialist access are motivating AI decision-support adoption to help determine ...
Emirates News Agency on MSN
DoH celebrates UAE’s first paediatric cardiac biopsy as part its visiting physicians ...
ABU DHABI, 12th March, 2026 (WAM) -- The Department of Health – Abu Dhabi (DoH), regulator of the healthcare sector in the emirate, announced a significant milestone with the successful completion of ...
The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...
Zacks Investment Research on MSN
ISRG's da Vinci gains FDA nod for cardiac surgery: TAM growth ahead?
Intuitive Surgical ISRG is positioning cardiac surgery as a long-term growth lever for the da Vinci 5 platform following recent regulatory progress. The company recently received FDA clearance for ...
Methodist Healthcare is using AI-assisted imaging to detect soft plaque in arteries, a leading contributor to heart attacks in the U.S.
The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR([1]) . Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand ...
The global cardiac monitoring and cardiac rhythm management devices market is expected to grow from $27.90b in 2026 to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果